Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 181

1.

Glycosylation of uroplakins. Implications for bladder physiopathology.

Kątnik-Prastowska I, Lis J, Matejuk A.

Glycoconj J. 2014 Dec;31(9):623-36. doi: 10.1007/s10719-014-9564-4. Epub 2014 Nov 15. Review.

2.

Using sugar remodeling to study chondroitin sulfate function.

Kitagawa H.

Biol Pharm Bull. 2014;37(11):1705-12. Review.

3.

The emerging link between O-GlcNAc and Alzheimer disease.

Zhu Y, Shan X, Yuzwa SA, Vocadlo DJ.

J Biol Chem. 2014 Dec 12;289(50):34472-81. doi: 10.1074/jbc.R114.601351. Epub 2014 Oct 21. Review.

4.

O-GlcNAc and the epigenetic regulation of gene expression.

Lewis BA, Hanover JA.

J Biol Chem. 2014 Dec 12;289(50):34440-8. doi: 10.1074/jbc.R114.595439. Epub 2014 Oct 21. Review.

5.

Multiple tissue-specific roles for the O-GlcNAc post-translational modification in the induction of and complications arising from type II diabetes.

Vaidyanathan K, Wells L.

J Biol Chem. 2014 Dec 12;289(50):34466-71. doi: 10.1074/jbc.R114.591560. Epub 2014 Oct 21. Review.

6.

O-GlcNAcase: promiscuous hexosaminidase or key regulator of O-GlcNAc signaling?

Alonso J, Schimpl M, van Aalten DM.

J Biol Chem. 2014 Dec 12;289(50):34433-9. doi: 10.1074/jbc.R114.609198. Epub 2014 Oct 21. Review.

7.

Cancer metabolism and elevated O-GlcNAc in oncogenic signaling.

Ma Z, Vosseller K.

J Biol Chem. 2014 Dec 12;289(50):34457-65. doi: 10.1074/jbc.R114.577718. Epub 2014 Oct 21. Review.

8.

Protein O-GlcNAcylation and cardiovascular (patho)physiology.

Marsh SA, Collins HE, Chatham JC.

J Biol Chem. 2014 Dec 12;289(50):34449-56. doi: 10.1074/jbc.R114.585984. Epub 2014 Oct 21. Review.

9.

Managing the pain of knee osteoarthritis.

Hrnack SA, Barber FA.

Phys Sportsmed. 2014 Sep;42(3):63-70. doi: 10.3810/psm.2014.09.2077. Review.

PMID:
25295768
10.
11.

Role of O-GlcNAcylation in nutritional sensing, insulin resistance and in mediating the benefits of exercise.

Myslicki JP, Belke DD, Shearer J.

Appl Physiol Nutr Metab. 2014 Nov;39(11):1205-13. doi: 10.1139/apnm-2014-0122. Epub 2014 Jul 28. Review.

PMID:
25203141
12.

Elosulfase Alfa: a review of its use in patients with mucopolysaccharidosis type IVA (Morquio A syndrome).

Lyseng-Williamson KA.

BioDrugs. 2014 Oct;28(5):465-75. doi: 10.1007/s40259-014-0108-z. Review.

PMID:
25200032
13.

Sulfated sugars in the extracellular matrix orchestrate ovarian cancer development: 'when sweet turns sour'.

Vallen MJ, van der Steen SC, van Tilborg AA, Massuger LF, van Kuppevelt TH.

Gynecol Oncol. 2014 Nov;135(2):371-81. doi: 10.1016/j.ygyno.2014.08.023. Epub 2014 Aug 23. Review.

PMID:
25158037
14.

Drugs for osteoarthritis.

[No authors listed]

Med Lett Drugs Ther. 2014 Sep 1;56(1450):80-4. Review. No abstract available.

PMID:
25157683
15.

The potential role of O-GlcNAc modification in cancer epigenetics.

Forma E, Jóźwiak P, Bryś M, Krześlak A.

Cell Mol Biol Lett. 2014 Sep;19(3):438-60. doi: 10.2478/s11658-014-0204-6. Epub 2014 Aug 20. Review.

PMID:
25141978
16.

Sea, carbohydrates and clotting: a triad on the road of drug discovery.

Pomin VH.

Mini Rev Med Chem. 2014;14(9):717-24. Review.

PMID:
25138087
17.

Nutrient regulation of signaling, transcription, and cell physiology by O-GlcNAcylation.

Hardivillé S, Hart GW.

Cell Metab. 2014 Aug 5;20(2):208-13. doi: 10.1016/j.cmet.2014.07.014. Review.

18.

Chemical tools to explore nutrient-driven O-GlcNAc cycling.

Kim EJ, Bond MR, Love DC, Hanover JA.

Crit Rev Biochem Mol Biol. 2014 Jul-Aug;49(4):327-42. doi: 10.3109/10409238.2014.931338. Review.

PMID:
25039763
19.

X marks the spot: does it matter that O-GlcNAc transferase is an X-linked gene?

Olivier-Van Stichelen S, Abramowitz LK, Hanover JA.

Biochem Biophys Res Commun. 2014 Oct 17;453(2):201-7. doi: 10.1016/j.bbrc.2014.06.068. Epub 2014 Jun 21. Review.

20.

Mechanisms of axon regeneration and its inhibition: roles of sulfated glycans.

Kadomatsu K, Sakamoto K.

Arch Biochem Biophys. 2014 Sep 15;558:36-41. doi: 10.1016/j.abb.2014.06.009. Epub 2014 Jun 18. Review.

PMID:
24951877

Supplemental Content

Loading ...
Support Center